Ppar-α Independent Effect of Fenofibrate on Glioblastoma Cancer Cell Metabolism and Survival

Gliobastoma multiforme is the most common and aggressive primary brain tumour in adults. It is characterized by a rapid cell growth, CNS infiltration and is resistant to all known anti-cancer regimes. The development of effective therapies against these malignant brain tumours represents a challenge for contemporary medicine. Therefore, anti-neoplastic potential of a common lipid-lowering drug, fenofibrate, is gaining attention. In this poster learn about the ppar-α independent actions of fenofibrate.